1. Home
  2. YPF vs EXEL Comparison

YPF vs EXEL Comparison

Compare YPF & EXEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo YPF Sociedad Anonima

YPF

YPF Sociedad Anonima

N/A

Current Price

$37.18

Market Cap

18.4B

Sector

Energy

ML Signal

N/A

Logo Exelixis Inc.

EXEL

Exelixis Inc.

N/A

Current Price

$69.95

Market Cap

17.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
YPF
EXEL
Founded
1977
1994
Country
Argentina
United States
Employees
N/A
N/A
Industry
Integrated oil Companies
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.4B
17.8B
IPO Year
1995
2000

Fundamental Metrics

Financial Performance
Metric
YPF
EXEL
Price
$37.18
$69.95
Analyst Decision
Buy
Buy
Analyst Count
13
17
Target Price
$60.78
★ $61.57
AVG Volume (30 Days)
1.3M
★ 2.5M
Earning Date
10-29-2026
10-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 57.95
EPS
N/A
★ 2.46
Revenue
N/A
★ $452,477,000.00
Revenue This Year
$58.16
$10.14
Revenue Next Year
N/A
$12.56
P/E Ratio
★ N/A
$28.89
Revenue Growth
N/A
N/A
52 Week Low
$32.74
$39.71
52 Week High
$57.87
$73.69

Technical Indicators

Market Signals
Indicator
YPF
EXEL
Relative Strength Index (RSI) 21.37 62.76
Support Level $36.04 $55.28
Resistance Level $39.96 N/A
Average True Range (ATR) 2.02 2.45
MACD -1.06 0.04
Stochastic Oscillator 4.73 61.25

Price Performance

Historical Comparison
YPF
EXEL

About YPF YPF Sociedad Anonima

YPF SA is an Argentina-based integrated oil and gas company. The company operates through four business segments: Upstream, Midstream and Downstream, LNG and Integrated Gas, and New Energies. The Upstream segment focuses on the exploration and production of crude oil and natural gas. The Midstream and Downstream segment includes refining, transportation, and commercialization of crude oil, refined, and petrochemical products. The LNG and Integrated Gas segment is involved in natural gas transportation, processing, storage, and commercialization. The New Energies segment focuses on energy transition initiatives, including natural gas distribution, power generation, renewable energy, and related technology development. It generates majority of revenue from Midstream and Downstream segment.

About EXEL Exelixis Inc.

Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.

Share on Social Networks: